What Do Zyns Do to You? Effects on Your Body

Placing a Zyn pouch between your lip and gum delivers nicotine through the oral mucosa and into your bloodstream, triggering a cascade of effects across multiple organ systems. The nicotine hits more slowly than a cigarette but can ultimately deliver a comparable total dose, and it brings with it real cardiovascular, oral, gastrointestinal, and neurological consequences. Because these products arrived on the market recently, some of those consequences are well documented while others remain genuinely unknown.

How the Nicotine Actually Gets In

Nicotine from a Zyn pouch absorbs through the lining of your mouth, which is thinner and more blood-vessel-rich than skin. The experience feels different from smoking because the delivery curve is fundamentally different. A cigarette gets nicotine to peak blood levels in about five to eight minutes. Nicotine pouches take roughly 20 to 65 minutes to reach their peak, depending on the strength of the pouch.¹ That slower ramp-up is part of why pouches feel less intense moment-to-moment than inhaling smoke.

But the total amount of nicotine your body absorbs can be surprisingly close to what a cigarette delivers. A meta-analysis found that 4 mg pouches delivered about 92% of the total nicotine exposure of a cigarette, even though the peak blood concentration only reached about 69% of what smoking produces.¹ Higher-strength pouches close the gap further. One trial found that a 10 mg pouch actually exceeded the cigarette’s peak nicotine level and total exposure, though it still took about an hour to get there compared to seven minutes for the cigarette.² The practical takeaway: Zyns are not a low-nicotine product. Depending on the strength you choose, you can absorb as much nicotine as you would from a cigarette, just spread over a longer window.

What Happens to Your Heart and Blood Vessels

Nicotine is a stimulant, and your cardiovascular system feels it regardless of how the nicotine arrives. When you use a pouch, your sympathetic nervous system ramps up. Studies examining nicotine pouches specifically have documented dose-dependent increases in heart rate, blood pressure, and markers of arterial stiffness shortly after use.³ These are acute effects, meaning they happen within minutes and fade as nicotine clears, but repeated daily exposure keeps your cardiovascular system in a chronically elevated state.

The longer-term cardiovascular picture is less clear but concerning. Mechanistic research points to nicotine-driven pathways including endothelial dysfunction, where the inner lining of blood vessels stops working properly, and increased arterial stiffness, which forces the heart to work harder to push blood through less flexible vessels.⁴ Because nicotine pouches haven’t been around long enough for large-scale cardiovascular outcome studies, researchers draw partly on data from Swedish snus, a similar oral nicotine product with decades of epidemiological follow-up. That evidence is suggestive but imperfect, since snus contains some tobacco-specific compounds that Zyns lack. The honest summary is that the short-term cardiovascular stress is well established, and the long-term risk is biologically plausible but not yet quantified for pouches specifically.

What Happens Inside Your Mouth

Your gums and the soft tissue lining your mouth take the most direct hit. The pouch sits in one spot for 20 to 60 minutes at a time, bathing a small patch of tissue in nicotine and flavoring compounds. Clinical case reports have documented two specific problems at those placement sites: gingival recession, where the gum tissue pulls away from the tooth, and leukoplakia, a white patch on the mucosa that dentists watch closely because some forms can be precancerous.⁵ In those reported cases, the lesions appeared at the exact spots where healthy young men habitually placed their pouches, pointing to a combination of mechanical irritation from the pouch itself and chemical irritation from its contents.

Beyond what you can see, nicotine affects gum tissue at a cellular level. It interacts with cells involved in the inflammatory response and can suppress the fibroblasts that maintain the connective tissue holding teeth in place. Over time, this disruption to normal tissue maintenance and microbial balance may contribute to periodontal disease.⁶ If you use pouches regularly, rotating the placement side can at least spread the mechanical stress around. But no amount of rotation eliminates the chemical exposure your oral tissue is absorbing.

The Gut Symptoms People Don’t Expect

One of the more underappreciated effects of nicotine pouches is gastrointestinal discomfort. Because you inevitably swallow some nicotine-laced saliva while the pouch is in, your digestive system gets a dose too. A cross-sectional study of adult pouch users found that roughly two-thirds reported bloating, nearly half experienced nausea, and similar numbers reported heartburn, stomach pain, and constipation.⁷ These are self-reported numbers from a single survey, so they should be taken as a rough indication rather than a precise prevalence rate. Still, the pattern is consistent with what nicotine does to gut motility and acid secretion: it stimulates stomach acid production and can disrupt normal digestive rhythms.

New users tend to feel these effects most strongly. Nicotine is an emetic at higher doses, meaning it triggers the nausea reflex, and if you’re not habituated, even a moderate-strength pouch can leave you feeling queasy. Most regular users develop tolerance to the nausea over days or weeks, though bloating and acid reflux often persist.

Your Brain on Nicotine Pouches

Nicotine’s appeal comes down to what it does in your brain. It binds to nicotinic acetylcholine receptors, which triggers the release of dopamine and other neurotransmitters associated with reward, alertness, and focus. People who use Zyns reliably report increased wakefulness and sharper attention, and those effects are real and well documented.⁸ The flip side is that your brain adapts. Tolerance develops, meaning you need more nicotine to get the same cognitive lift, and withdrawal sets in when you stop, bringing irritability, difficulty concentrating, and restlessness.

Flavored products may amplify some of these reward pathways. Preclinical research has found that certain common flavorants, including menthol and fruit-type compounds, can enhance nicotine’s reinforcing effects by modulating dopamine activity in reward-mediating brain areas.⁹ In practical terms, this means the mint or wintergreen Zyn you chose partly because it tastes good may also be slightly better at training your brain to want more.

Why the Risks Are Different for Adolescents

The developing brain is significantly more vulnerable to nicotine than the adult brain. Key regions responsible for attention, learning, mood regulation, and impulse control continue maturing into the mid-twenties. Nicotine exposure during this period can cause lasting changes to those circuits, and there is evidence linking adolescent nicotine use to elevated risk for future addiction to other substances.¹⁰ The “tobacco-free” label on Zyns sometimes creates a false sense of safety among younger users, but nicotine itself, regardless of its delivery vehicle, is the primary concern for the adolescent brain.⁹

Mood, Sleep, and the Psychological Side

Many people reach for nicotine as a stress reliever, but the relationship between nicotine and mental health is more complicated than it feels in the moment. A cross-sectional study of nicotine product users found high rates of self-reported psychological symptoms: about three-quarters reported difficulty concentrating, trouble sleeping, and increased anxiety or irritability, while roughly 70% reported depression, anger management difficulties, and stress.¹¹ A cross-sectional survey cannot tell you whether nicotine caused those symptoms or whether people with those symptoms are more likely to use nicotine. Probably both dynamics are at work. What is clear is that chronic nicotine use does not reliably improve mental health, even when each individual dose feels calming.

Sleep disruption deserves its own mention. Nicotine is a stimulant, and using a pouch in the evening can delay sleep onset and reduce sleep quality. People who use nicotine products regularly tend to report more daytime sleepiness despite getting objectively less restorative sleep.⁸ Tolerance can mask this effect, since long-term users may not feel wired the way a new user does, but the underlying sleep architecture often remains disrupted.

What About Cancer Risk

This is the question that matters most to a lot of people, and the honest answer is that we don’t know yet for the long term. In the short-term toxicology picture, nicotine pouches look vastly cleaner than cigarettes or traditional chewing tobacco. A chemical analysis of ZYN products found that 38 of 43 tested harmful compounds were below measurable levels, including all tested nitrosamines and polycyclic aromatic hydrocarbons, which are the classes of carcinogens most associated with tobacco-caused cancer.¹² Laboratory studies have found that nicotine pouches are not mutagenic or genotoxic in standard cell-based assays, though they do show some cytotoxicity, meaning they can damage cells at high concentrations.¹³

The important caveat is that no long-term epidemiological data exist. Nicotine pouches have only been widely available for a handful of years, and cancer typically takes decades to develop. Researchers have noted that while existing evidence suggests much lower risk compared to combustible tobacco, the long-term implications for oral carcinogenesis remain genuinely unclear.¹⁴ It’s also worth noting that a broad screening of 48 nicotine pouch products from various manufacturers identified 186 different chemical components beyond nicotine, and a few of those, including methyl eugenol and benzophenone, are classified as possibly carcinogenic by the International Agency for Research on Cancer.¹³ These are present at low levels, but their long-term significance with chronic daily use is unknown.

How Flavor Choice Changes the Equation

Not all Zyns affect your oral tissue equally. Laboratory testing has found that the toxicity of nicotine pouch extracts varies meaningfully by flavor category. In one study using human gingival epithelial cells, fruit-flavored pouches produced the greatest cell damage, while menthol-flavored pouches triggered the strongest release of a particular inflammatory marker. Tobacco-flavored and fruit-flavored products increased the production of reactive oxygen species, molecules that damage cells through oxidative stress, but menthol-flavored products did not.¹⁵ These are cell-culture results, so they don’t translate directly to what happens in a living mouth, but they suggest that your flavor choice is not purely cosmetic. The flavoring chemicals are biologically active.

Nicotine Pouches Versus Cigarettes as a Harm Calculus

If you’re already a smoker, the comparison to cigarettes is where things get more nuanced. The harms of smoking come overwhelmingly from combustion, from the tar, carbon monoxide, and thousands of toxic byproducts generated when tobacco burns. Nicotine pouches eliminate combustion entirely. That chemical cleanliness shows up in the data: the vast majority of known carcinogens and toxicants measured in ZYN pouches fall below detectable levels, putting them roughly on par with pharmaceutical nicotine replacement products in terms of harmful constituents.¹²

A small pilot trial tested whether giving smokers nicotine pouches helped them cut down. Both groups receiving pouches (3 mg and 6 mg) significantly reduced the number of cigarettes they smoked per day over four weeks. The higher-dose group showed a non-significant trend toward greater reduction and was more likely to report complete abstinence from smoking, though the study was too small to reach statistical significance on those outcomes.¹⁶ Separately, researchers who compared the nicotine delivery profile and effects on urge to smoke concluded that pouches have good potential to serve as an effective replacement for smoking.¹⁷

None of this means pouches are safe in an absolute sense. It means that for someone currently smoking a pack a day, switching to nicotine pouches likely reduces their exposure to the compounds most responsible for smoking-related disease. For someone who doesn’t use any nicotine product, starting Zyns introduces cardiovascular, oral, and addiction risks with no offsetting benefit.

Metabolic Effects and Weight

One reason some users report weight changes with nicotine is that nicotine genuinely affects metabolism. Animal research has shown that chronic nicotine exposure reduces weight gain and lowers blood insulin levels while improving insulin sensitivity, effects mediated through specific nicotinic receptor pathways.¹⁸ Nicotine also suppresses appetite centrally, which is why quitting any nicotine product commonly leads to weight gain. These metabolic effects are real, but using nicotine as a weight management tool carries obvious downsides given everything else it does to your body. And the appetite-suppressing effect wanes with tolerance, so long-term users may not sustain the early weight effects anyway.

The Labeling Problem You Should Know About

If you pick up nicotine pouches at a gas station, you might assume the packaging tells you exactly what’s inside. It often doesn’t. An analysis of nicotine pouch labeling found that many products do not clearly state their nicotine content in milligrams. Instead, manufacturers use vague strength descriptors like “strong” or “extra strong,” or arbitrary dot-based scoring systems that are neither standardized nor explained.¹⁹ The actual nicotine behind those labels varies widely between brands, so a “strong” pouch from one company might deliver more or less nicotine than a “strong” from another. Some products had no indication of nicotine content at all.

On a slightly more reassuring note, when products do state a milligram number, the measured nicotine content tends to be at or below the labeled amount, meaning manufacturers generally aren’t putting more nicotine in than advertised.²⁰ The issue isn’t fraud so much as a lack of regulatory standards requiring clear, consistent labeling. If you’re trying to manage your nicotine intake, look for products that list actual milligrams per pouch rather than relying on subjective strength descriptors.

Nicotine During Pregnancy

Nicotine in any form poses risks during pregnancy, though the picture is more complicated than a blanket prohibition might suggest. Research on nicotine replacement therapy in pregnant smokers found that NRT use was associated with higher birth weight and longer gestational age compared to placebo, with substantially lower rates of low-birth-weight infants and preterm birth in the NRT group.²¹ That sounds paradoxical until you remember the comparison group: women who were still smoking. Nicotine alone, while not harmless, appears to be substantially less damaging to fetal development than the full cocktail of combustion products in cigarette smoke. No study has specifically examined Zyn use during pregnancy, so any conversation about that should happen with a physician who can weigh individual circumstances.

What Zyns Don’t Do to Athletic Performance

There is a persistent belief, especially among younger users, that nicotine pouches boost athletic performance. The evidence doesn’t support much of a claim here. A review that examined ten studies using nicotine or smokeless tobacco as an intervention for muscular strength, endurance, and high-intensity exercise found that only two studies detected any performance-enhancing effect. One study actually found a performance decrease, and the remaining seven found no change at all.²² If there is an ergogenic effect from nicotine, it is small and inconsistent enough that it hasn’t shown up reliably in controlled studies. The alertness and focus boost some athletes report likely reflects nicotine’s well-documented cognitive stimulant properties rather than any direct muscular or cardiorespiratory enhancement.

1
PubMed Central. Nicotine pouch pharmacokinetics compared to smoked tobacco: A systematic review and meta-analysis
2
PubMed Central. A Randomised Study to Investigate the Nicotine Pharmacokinetics of Oral Nicotine Pouches and a Combustible Cigarette
3
PubMed Central. Nicotine pouches and youth: emerging patterns and potential cardiovascular risks
4
PubMed. Snus, nicotine pouches and cardiovascular disease: Evidence, mechanisms, and the challenge of novel nicotine products
5
PubMed Central. Localized gingival recession and leukoplakia associated with nicotine pouch use: two clinical case reports
6
PubMed Central. Emerging Oral Nicotine Products and Periodontal Diseases
7
Tobacco Prevention and Cessation. Assessing the gastrointestinal and psychological impacts of nicotine pouch use among adults in Saudi Arabia: A cross-sectional study
8
PubMed Central. Effects of Nicotine on the Central Nervous System and Sleep Quality in Relation to Other Stimulants: A Narrative Review
9
Current Problems in Pediatric and Adolescent Health Care. An update on nicotine use in adolescents
10
Public Health. Oral nicotine pouches: Rising popularity of a new class of tobacco products among youth
11
PubMed Central. Nicotine Negatively Affects Its Users’ Health and Psychology in Saudi Arabia: A Cross-Sectional Study
12
PubMed Central. Harmful and potentially harmful constituents (HPHCs) in two novel nicotine pouch products in comparison with regular smokeless tobacco products and pharmaceutical nicotine replacement therapy products (NRTs)
13
Nicotine & Tobacco Research. The Potential Impact of Oral Nicotine Pouches on Public Health: A Scoping Review
14
PubMed Central. Nicotine pouches, oral cancer and tobacco harm reduction: current evidence and research priorities
15
PubMed Central. Flavor Classification/Categorization and Differential Toxicity of Oral Nicotine Pouches (ONPs) in Oral Gingival Epithelial Cells and Bronchial Epithelial Cells
16
PubMed Central. The Effects of Oral Nicotine Pouches on Cigarette Smoking Behavior and Tobacco Harm Exposure: A Randomized Pilot Trial in Adults
17
PubMed. Nicotine delivery from and user reactions to nicotine pouches compared to cigarettes
18
PubMed Central. Chronic exposure to nicotine enhances insulin sensitivity through α7 nicotinic acetylcholine receptor-STAT3 pathway
19
PubMed. Levels of nicotine and tobacco-specific nitrosamines in oral nicotine pouches
20
PubMed. Total and unprotonated (freebase) nicotine content in new types of oral ‘tobacco-free’ nicotine products
21
PubMed Central. Safety of Nicotine Replacement Therapy during Pregnancy: A Narrative Review
22
PubMed Central. Nicotine: Sporting Friend or Foe? A Review of Athlete Use, Performance Consequences and Other Considerations